METTL14 and gastric cancer: As identified by rescue experiments and validated by methylated RNA immunoprecipitation (Me-RIP), METTL14 knockdown reduced circORC5 m6A levels, which correlated negatively with miR-30c-2-3p and indicated poor survival in GC [22].